GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (OTCPK:SGBI) » Definitions » Pretax Margin %

Sangui Biotech International (Sangui Biotech International) Pretax Margin % : -200.00% (As of Mar. 2023)


View and export this data going back to . Start your Free Trial

What is Sangui Biotech International Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sangui Biotech International's Pre-Tax Income for the three months ended in Mar. 2023 was $-0.04 Mil. Sangui Biotech International's Revenue for the three months ended in Mar. 2023 was $0.02 Mil. Therefore, Sangui Biotech International's pretax margin for the quarter that ended in Mar. 2023 was -200.00%.

The historical rank and industry rank for Sangui Biotech International's Pretax Margin % or its related term are showing as below:


SGBI's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.555
* Ranked among companies with meaningful Pretax Margin % only.

Sangui Biotech International Pretax Margin % Historical Data

The historical data trend for Sangui Biotech International's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Pretax Margin % Chart

Sangui Biotech International Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -280.52 -389.77 -686.21 -309.09 -91.30

Sangui Biotech International Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -83.33 -90.91 60.98 -936.36 -200.00

Competitive Comparison of Sangui Biotech International's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sangui Biotech International's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's Pretax Margin % falls into.



Sangui Biotech International Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Sangui Biotech International's Pretax Margin for the fiscal year that ended in Jun. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-0.063/0.069
=-91.30 %

Sangui Biotech International's Pretax Margin for the quarter that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-0.038/0.019
=-200.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sangui Biotech International  (OTCPK:SGBI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Sangui Biotech International Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sangui Biotech International (Sangui Biotech International) Business Description

Traded in Other Exchanges
Address
Bleichenbrucke 9, Hamburg, DEU, 20354
Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.
Executives
Hubertus Schmelz director NEUER WALL 54, HAMBURG 2M D-20354
Joachim Fleing director ALFRED HERRHAUSENSTR 44, WITTEN 2M 58455
Thomas Striepe director NEUER WALL 54, HAMBURG 2M D-20354
Wolfgang Barnikol director ALFRED HERRHAUSEN STR 44, WITTEN 2M 58455
Lutz Joachim director ALFRED-HERRHAUSEN-ST. 44, WITTEN 2M 58455
Christoph Ludz director SANDERSKOPPEL 17, HAMBURG 2M 22391

Sangui Biotech International (Sangui Biotech International) Headlines

No Headlines